Ischemic Stroke Clinical Trial
Official title:
Cranial Temperature, as an Early Diagnosis Marker for Hemorrhagic and Ischemic Stroke
The cerebrovascular diseases can be approximately divided as two types, namely ischemic and
hemorrhagic stroke. Intravenous thrombolysis within 3-4.5 hours is highly recommended for
acute ischemic stroke patients. But it's difficult to diagnose the ischemic stroke with the
hemorrhagic stroke from the early symptoms and signs. It's with high risk of enlarging the
hematoma if the patients with hemorrhagic stroke received the thrombolytic drugs. And time
cost by CT or MRI examination is likely to responsible for missing the narrow time window
and poor prognosis of stroke patients. Consequently, seeking for a noninvasive, rapid,
portable and inexpensive diagnosis method which can sensitively distinguish the stroke type
before CT or MRI examination would be very helpful in treating the ischemic stroke patients.
Because of the blockage in the cerebral supply artery, the heat from circulatory system will
sharply decrease in infracted hemisphere among the ischemic stroke patients. The reduced
brain temperature influenced the temperature on the ipsilateral forehead according to the
data of our animal and preliminary clinical trial. In contrast, the temperature of the
ipsilateral hemisphere showed a mild increase among the ischemic stroke patients in our
preliminary experiment. The difference of the temperature tendency on the ipsilateral
forehead has a great chance to be an early physical mark.
In our study, 30 ischemic stroke patients and 30 hemorrhagic stroke patients will be
recruited. In the process of recruitment, the patients with acute stroke attack in no more
than 4.5 hours will be collected the temperature at the five point without head coverage,
including ipsilateral tempora, ipsilateral forehead, galbella, contralateral forehead, and
contralateral tempora. Then the stroke would be recruited into the ischemic and hemorrhagic
group according to the later CT or MRI results in the hospital. The accuracy and sensibility
of early brain temperature in distinguishing stroke type would be tested in comparison with
the diagnosis of imaging examination.
Stroke is the leading cause of morbidity and disability among the aged population around the
world, and its incidence is still rising recently. The cerebrovascular diseases can be
approximately divided as two types, namely ischemic and hemorrhagic stroke. Their
pathophysiological processes and therapeutical strategies are totally different. For
hemorrhagic stroke, which takes up about 20% patients with cerebrovascular diseases, there
is a lack of valid medical management in the very early stage except surgical hematoma
removal. Whereas it's the key management for ischemic stroke to recanalize the occluded
artery and restore blood flow before the irreversible brain damage. According the Guidelines
for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack,
intravenous thrombolysis within 3-4.5 hours is highly recommended for acute ischemic stroke
patients. The time window of thrombolysis after ischemic stroke is extremely narrow and
greatly affected the patients' outcomes.
Despite the efficacious therapy exists, the rate of successful early thrombolysis is still
awfully low, especially in the developing countries. Only 3-5% stroke patients can take
advantage of the early thrombolysis. There are two major reasons response for such a low
successful thrombolysis rate, including the civilian and some first-aid personnel hasn't
mastered the timing of thrombolysis therapy for ischemic stroke. That would be improved by
propaganda and education of the stroke knowledge. But what's more critical is the difficulty
to diagnose the ischemic stroke with the hemorrhagic stroke from the early symptoms and
signs. It's with high risk of enlarging the hematoma if the patients with hemorrhagic stroke
received the thrombolytic drugs. For this reason, it's hard for the doctors to provide the
correct treatment at the first time before imaging examination finished. And the time cost
by CT or MRI examination is likely to responsible for missing the narrow time window and
poor prognosis of stroke patients. Consequently, seeking for a noninvasive, rapid, portable
and inexpensive diagnosis method which can sensitively distinguish the stroke type before CT
or MRI examination would be very helpful in treating the ischemic stroke patients. The new
method would enable the first-aid personnel to judge the stroke type in the ambulance and
decide to apply intravenous thrombolysis or not.
Because of the blockage in the cerebral supply artery, especially the cerebral middle artery
which can't be compensated, the blood flow in the corresponding hemisphere would drop
sharply among the ischemic stroke patients. Along with decreasing heat from circulatory
system, the infracted hemisphere's temperature should drop. The reduced brain temperature
influenced the temperature on the ipsilateral forehead according to the data of our animal
and preliminary clinical trial. In contrast, the temperature of the ipsilateral hemisphere
showed a mild increase among the ischemic stroke patients in our preliminary experiment.
That's possibly because the early mitochondrial dysfunction and inflammatory reaction
induced by the hematoma. The difference of the temperature tendency on the ipsilateral
forehead has a great chance to be an early physical mark. Temperature test could be rapid
and noninvasive, making this mark a promising method to help the doctors to distinguish the
stroke type in very early stage. Earlier diagnosis of ischemic stroke means earlier
thrombolysis and much better prognosis.
In our study, 30 ischemic stroke patients and 30 hemorrhagic stroke patients will be
recruited. In the process of recruitment, the patients with acute stroke attack in no more
than 4.5 hours will be collected the temperature at the five point without head coverage,
including ipsilateral tempora, ipsilateral forehead, galbella, contralateral forehead, and
contralateral tempora. Then the stroke would be recruited into the ischemic and hemorrhagic
group according to the later CT or MRI results in the hospital. The accuracy and sensibility
of early brain temperature in distinguishing stroke type would be tested in comparison with
the diagnosis of imaging examination. It should be emphasized that the diagnosis and
following treatment should depend on the imaging examination and our brain temperature test
is rapid and noninvasive. The therapy of the recruited stroke patients wouldn't be
influenced by the trial and should be as usual as the standard therapy.
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Recruiting |
NCT05518305 -
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
|
||
Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
Recruiting |
NCT03728738 -
Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke
|
Phase 3 | |
Terminated |
NCT03396419 -
IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
|
||
Recruiting |
NCT05065216 -
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
|
Phase 2/Phase 3 | |
Recruiting |
NCT04897334 -
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
|
N/A | |
Not yet recruiting |
NCT06462599 -
Osteopontin Gene Polymorphism in Stroke Patients in Egypt
|
||
Not yet recruiting |
NCT06026696 -
Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
|
||
Not yet recruiting |
NCT06032819 -
Differentiating Between Brain Hemorrhage and Contrast
|
||
Recruiting |
NCT02910180 -
Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
|
||
Completed |
NCT02922452 -
A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT03554642 -
Walkbot Robotic Training for Improvement in Gait
|
Phase 3 | |
Withdrawn |
NCT01866189 -
Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke
|
N/A | |
Recruiting |
NCT03041753 -
Reperfusion Injury After Stroke Study
|
N/A | |
Completed |
NCT02549846 -
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
|
Phase 4 | |
Completed |
NCT02610803 -
Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke
|
N/A | |
Completed |
NCT01678534 -
Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial
|
Phase 2 |